Northwest & Ethical Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,398
| Closed | -$1.15M | – | 410 |
|
|
2023
Q1 | $1.15M | Hold |
1,398
| – | – | 0.04% | 294 |
|
|
2022
Q4 | $1.01M | Sell |
1,398
-830
| -37% | -$599K | 0.03% | 298 |
|
|
2022
Q3 | $1.53M | Sell |
2,228
-61
| -3% | -$42K | 0.06% | 256 |
|
|
2022
Q2 | $1.35M | Hold |
2,289
| – | – | 0.05% | 272 |
|
|
2022
Q1 | $1.6M | Buy |
+2,289
| New | +$1.6M | 0.05% | 267 |
|
|
2020
Q2 | – | Sell |
-2,788
| Closed | -$1.36M | – | 411 |
|
|
2020
Q1 | $1.36M | Buy |
2,788
+69
| +3% | +$33.7K | 0.08% | 259 |
|
|
2019
Q4 | $1.02M | Sell |
2,719
-986
| -27% | -$370K | 0.05% | 320 |
|
|
2019
Q3 | $1.03M | Buy |
+3,705
| New | +$1.03M | 0.05% | 312 |
|
|
2015
Q3 | – | Sell |
-16,000
| Closed | -$8.16M | – | 218 |
|
|
2015
Q2 | $8.16M | Buy |
+16,000
| New | +$8.16M | 0.54% | 55 |
|